PDF (3.5 MB)
Collect
Submit Manuscript
Open Access

Astragalin and rutin restore gut microbiota dysbiosis, alleviate obesity and insulin resistance in high-fat diet-fed C57BL/6J mice

Muni Swamy Ganjayia,bKarunakaran Reddy SankaranaBalaji Merigaa()Ruchika BhatiacShikha SharmacKanthi Kiran Kondepudic
Department of Biochemistry, Sri Venkateswara University, Tirupati 517502, India
Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens 45701, United States
Food and Nutrition Biotechnology Division, National Agri-Food Biotechnology Institute, SAS Nagar, Punjab 140306, India

Peer review under responsibility of Tsinghua University Press.

Show Author Information

Highlights

• CAR restored HFD-induced gut-microbial dysbiosis and enhanced SCFAs synthesis.

• CAR attenuated obesity and insulin-resistance in terms of body composition and glycemic parameters.

• CAR modulated PPAR-γ and AMPK mediated signaling pathway to alleviate obesity disorders.

Graphical Abstract

View original image Download original image

Abstract

In the present study we investigated the impact of the combination of astragalin and rutin (CAR) on restoring gut-microbial dysbiosis and obesity and obesity related disorders. Randomized male C57BL/6J mice were experimentally divided into 5 groups and fed either a normal diet or a high-fat diet (HFD) for 16 weeks. Compared to vehicle treated group (HFD group), CAR could substantially improve selected gut microbiota abundance (Akkermansia, Lactobacillus, Bifidobacteria, Roseburia, Prevotella), reversed the Firmicutes/Bacteroidetes proportions, and inhibited the growth of Escherichia coli, Salmonella, and Klebsiella in obese mice. In addition, CAR-treated mice showed significantly increased total short-chain fatty acid production, reduced body weight gain, organs’ weights, serum lipid profile (except HDL) and insulin resistance. The mRNA expressions of CCAAT/enhancer binding protein-α (C/EBP-α), sterol regulatory element-binding protein-1c (SREBP-1c), peroxisome proliferator-activated receptor-γ (PPAR-γ), acetyl-CoA carboxylase (ACC), adipocyte protein 2 (aP2), and fatty acid synthase (FAS) were downregulated (P < 0.05) and the protein expression of PPAR-γ was downregulated while adenosine 5’ monophosphate-activated protein kinase (AMPK) was phosphorylated in CAR-treated HFD-fed mice compared to the HFD control group. Interestingly, CAR-treated HFD-fed mice showed significantly improved tissue architecture in the liver and fatty tissues. In conclusion, the findings suggest that CAR/Moringa oleifera may be beneficial in the treatment of insulin resistance and obesity disorders.

Electronic Supplementary Material

Download File(s)
fshw-13-6-3256_ESM.docx (25.7 KB)

References

[1]

F. Chen, S. Esmaili, G.B. Rogers, et al., Lean NAFLD: a distinct entity shaped by differential metabolic adaptation, Hepatology 71 (2020) 1213-1227. https://doi.org/10.1002/hep.30908.

[2]

N.S. Kalupahana, N. Moustaid-Moussa, The renin-angiotensin system: a link between obesity, inflammation and insulin resistance, Obes. Rev. 13 (2012) 139-146. https://doi.org/10.1111/j.1467-789X.2011.00942.x.

[3]

I. Romieu, L. Dossus, S. Barquera, et al., Energy balance and obesity: what are the main drivers? Cancer Causes and Control 28 (2017) 247-258. https://doi.org/10.1007/s10552-017-0869-z.

[4]

World Health Organization, Noncommunicable Diseases Progress Monitor, Geneva, 2017.

[5]

M. Balaji, M.S. Ganjayi, G.E.N. Hanuma Kumar, et al., A review on possible therapeutic targets to contain obesity: the role of phytochemicals, Obes. Res. Clin. Pract. 10(4) (2016) 1-18. https://doi.org/10.1016/j.orcp.2015.12.004.

[6]

R.B. Birari, K.K. Bhutani, Pancreatic lipase inhibitors from natural sources: unexplored potential, Drug Discov. Today 12 (2007) 879-889. https://doi.org/10.1016/j.drudis.2007.07.024.

[7]

S. Eaimworawuthikul, P. Thiennimitr, N. Chattipakorn, et al., Diet-induced obesity, gut microbiota and bone, including alveolar bone loss, Arch. Oral Biol. 78 (2017) 65-81. https://doi.org/10.1016/j.archoralbio.2017.02.009.

[8]

W. Shen, M. Shen, X. Zhao, et al., Anti-obesity effect of Capsaicin in mice fed with high-fat diet is associated with an increase in population of the gut bacterium Akkermansia muciniphila, Front. Microbiol. 23 (2017) 272. https://doi.org/10.3389/fmicb.2017.00272.

[9]

R.A. Kemperman, G. Gross, S. Mondot, et al., Impact of polyphenols from black tea and red wine/grape juice on a gut model microbiome, Food. Res. Inter. 53 (2013) 659-669. https://doi.org/10.1016/j.foodres.2013.01.034.

[10]

X. Meng, A. Zhang, X. Wang, et al., A kaempferol-3-O-β-D-glucoside, intervention effect of astragalin on estradiol metabolism, Steroids 149 (2019) 108413. https://doi.org/10.1016/j.steroids.2019.05.005.

[11]

L. Gopalakrishnan, K. Doriya, D.S. Kumar, Moringa oleifera: a review on nutritive importance and its medicinal application, Food Sci. Hum. Wellness 5 (2016) 49-56. https://doi.org/10.1016/j.fshw.2016.04.001.

[12]

A. Riaz, A. Rasul, G. Hussain, et al., Astragalin: a bioactive phytochemical with potential therapeutic activities, Adv. Pharmacol. Sci. 2 (2018) 9794625. https://doi.org/10.1155/2018/9794625.

[13]

G. Muni Swamy, G. Ramesh, R. Devi Prasad, et al., Astragalin, (3-O-glucoside of kaempferol), isolated from Moringa oleifera leaves modulates leptin, adiponectin secretion and inhibits adipogenesis in 3T3-L1 adipocytes, Arch. Physiol. Biochem. 128 (2022) 938-944. https://doi.org/10.1080/13813455.2020.1740742.

[14]

G. Muni Swamy, B. Meriga, Therapeutic effect of Moringa oleifera leaf extracts on oxidative stress and key metabolic enzymes related to obesity, Int. J. Pharma. Sci. Res. 11 (2020) 1949-1957. https://doi.org/10.13040/IJPSR.0975-8232.11(4).1949-57.

[15]

B.J. Lamont, Y. Li, E. Kwan, et al., Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice, J. Clin. Invest. 122 (2012) 388-402. https://doi.org/10.1172/JCI42497.

[16]

S.M. Sarma, D.P. Singh, P. Singh, et al., Finger millet arabinoxylan protects mice from high-fat diet induced lipid derangements, inflammation, endotoxemia and gut bacterial dysbiosis, Int. J. Biol. Macromol. 106 (2018) 994-1003. https://doi.org/10.1016/j.ijbiomac.2017.08.100.

[17]

B.M. Popkin, S. Du, W.D. Green et al., Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships, Obe. Rev. 21 (2020) 1-17. https://doi.org/https://doi.org/10.1111/obr.13128.

[18]

R.J. Hernandez Bautista, A.M. Mahmoud, M. Konigsberg, et al., Obesity: pathophysiology, monosodium glutamate-induced model and anti-obesity medicinal plants, Biomed. Pharmacother. 111 (2019) 503-516. https://doi.org/10.1016/j.biopha.2018.12.108.

[19]

Y. Lu, C. Fan, P. Li, et al., Short chain fatty acids prevent high-fat-dietinduced obesity in mice by regulating g protein-coupled receptors and gut Microbiota, Sci. Rep. 28 (2016) 37589. https://doi.org/10.1038/srep37589.

[20]

N. Joseph, K. Vasodavan, N.A. Saipudin, et al., Gut microbiota and shortchain fatty acids (SCFAs) profiles of normal and overweight school children in Selangor after probiotics administration, J. Funct. Foods 57 (2019) 103-111. https://doi.org/10.1016/j.jff.2019.03.042.

[21]

R.A. Bagarolli, N. Tobar, A.G. Oliveira, et al., Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice, J. Nutr. Biochem. 50 (2017) 16-25. https://doi.org/10.1016/j.jnutbio.2017.08.006.

[22]

X. Zhang, Y. Zhao, J. Xu, et al., Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats, Sci. Rep. 23 (2015) 14405. https://doi.org/10.1038/srep14405.

[23]

Y. He, Y. Li, T. Zhao, et al., Ursolic acid inhibits adipogenesis in 3T3-L1 adipocytes through LKB1/AMPK pathway, PLoS ONE 8 (2013) e70135. https://doi.org/10.1371/journal.pone.0070135.

[24]

R. Krajmalnik-Brown, Z. E. Ilhan, D. W. Kang, et al., Effects of gut microbes on nutrient absorption and energy regulation, Nutr. Clin. Pract. 27 (2012) 201-214. https://doi.org/10.1177/0884533611436116.

[25]

C. Jing, Z. Wen, P. Zou, et al., Consumption of black legumes Glycine soja and Glycine max lowers serum lipids and alters the gut microbiome profile in mice fed a high-fat diet, J. Agric. Food Chem. 66 (2018) 7367-7375. https://doi.org/10.1021/acs.jafc.8b02016.

[26]

B.S. Wostmann, C. Larkin, A. Moriarty, et al., Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats, Lab. Anim. Sci. 33 (1983) 46-50.

[27]

H.V. Lin, A. Frassetto, E.J. Kowalik, et al., Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acidreceptor 3-independent mechanisms, PLoS ONE 7 (2012) e35240. https://doi.org/10.1371/journal.pone.0035240.

[28]

I. Nadal, A. Santacruz, A. Marcos, et al., Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents, Int. J. Obes. 33 (2009) 758-767. https://doi.org/10.1038/ijo.2008.260.

[29]

M. Cheng, X. Zhang, J. Zhu, et al., A metagenomics approach to the intestinal microbiome structure and function in high fat diet-induced obesity mice fed with oolong tea polyphenols, Food Funct. 9 (2018) 1079-1087. https://doi.org/10.1039/C7FO01570D.

[30]

W. Cao, F. Liu, R.W. Li, et al., Docosahexaenoic acid-rich fish oil prevented insulin resistance by modulating gut microbiome and promoting colonic peptide YY expression in diet-induced obesity mice, Food Sci. Hum. Wellness 11 (2022) 177-188. https://doi.org/10.1016/j.fshw.2021.07.018.

[31]

G. den Besten, A. Bleeker, A. Gerding, et al., Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation, Diabetes 64 (2015) 2398-2408. https://doi.org/10.2337/db14-1213.

[32]

M.S. Ganjayi, R.S. Karunakaran, S. Gandham et al., Quercetin-3-Orutinoside from Moringa oleifera downregulates adipogenesis and lipid accumulation and improves glucose uptake by activation of AMPK/Glut-4 in 3T3-L1 cells, Rev. Bras. Farmacogn. 33 (2023) 334-343. https://doi.org/10.1007/s43450-022-00352-9.

[33]

S. Anudeep, V.K. Prasanna, S.M. Adya, et al., Characterization of soluble dietary fiber from Moringa oleifera seeds and its immunomodulatory effects, Int. J. Biol. Macromol. 91 (2016) 656-662. https://doi.org/10.1016/j.ijbiomac.2016.06.013.

[34]

A.K. Madiraju, D.M. Erion, Y. Rahimi, et al., Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase, Nature 510 (2014) 542-546. https://doi.org/10.1038/nature13270.

[35]

A. Villarruel-Lopez, D.A. Lopez-de la Mora, O.D. Vazquez-Paulino, et al., Effect of Moringa oleifera consumption on diabetic rats, BMC Complement. Altern. Med. 18 (2018) 127. https://doi.org/10.1186/s12906-018-2180-2.

[36]

Y.K. Lee, W.S. Lee, J.T. Hwang, Det al., Curcumin exerts antidifferentiation effect through AMPKα-PPAR-γ in 3T3-L1 adipocytes and antiproliferatory effect through AMPKα-COX-2 in cancer cells, J. Agric. Food Chem. 57 (2009) 305-310. https://doi.org/10.1021/jf802737z.

[37]

J.U. Chinchu, M.C. Mohan, B. Prakash Kumar, Anti-obesity and lipid lowering effects of Varanadi kashayam (decoction) on high fat diet induced obese rats, Obes. Med. 17 (2020) 100170. https://doi.org/10.1016/j.obmed.2019.100170.

[38]

M. Ono, K. Fujimori, Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells, J. Agric. Food Chem. 59 (2011) 13346-13352. https://doi.org/10.1021/jf203490a.

[39]

V. Gangarapu, K. Yıldız, A.T. Ince, et al., Role of gut microbiota: obesity and NAFLD, Turk. J. Gastroenterol. 25 (2014) 133-140. https://doi.org/10.5152/tjg.2014.7886.

[40]

Y.H. Park, J.J. Lee, H.K. Son, et al., Antiobesity effects of extract from Spergularia marina griseb in adipocytes and high-fat diet-induced obese rats, Nutrients 12 (2020) 336. https://doi.org/10.3390/nu12020336.

[41]

B. Zhao, Y. Cui, X. Fan, et al., Anti-obesity effects of Spirulina platensis protein hydrolysate by modulating brain-liver axis in high-fat diet fed mice, PLoS ONE 14 (2019) e0218543. https://doi.org/10.1371/journal.pone.0218543.

[42]

R. S. Karunakaran, O. Lokanatha, G. Muni Swamy, et al., Anti-obesity and lipid lowering activity of bauhiniastatin-1 is mediated through PPAR-γ/AMPK expressions in diet-induced obese rat model, Front. Pharmacol. 12 (2021) 704074. https://doi.org/10.3389/fphar.2021.704074.

[43]

X. Fan, C. Zhang, S. Niu, et al., Ginsenoside Rg1 attenuates hepatic insulin resistance induced by high-fat and high-sugar by inhibiting inflammation, Eur. J. Pharmacol. 854 (2019) 247-255. https://doi.org/10.1016/j.ejphar.2019.04.027.

[44]

Y. Hong, Y. Lin, Q. Si, et al., Ginsenoside Rb2 alleviates obesity by activation of brown fat and induction of browning of white fat, Front. Endocrinol. 10 (2019) 153. https://doi.org/10.3389/fendo.2019.00153.

[45]

S. Yan, K. Wang, X. Wang, et al., Effect of fermented bee pollen on metabolic syndrome in high-fat diet-induced mice, Food Sci. Hum. Wellness 10 (2021) 345-355. https://doi.org/10.1016/j.fshw.2021.02.026.

[46]

C.S. Kong, J.A. Kim, S.S. Bak, et al., Anti-obesity effect of carboxymethyl chitin by AMPK and aquaporin-7 pathways in 3T3-L1 adipocytes, J. Nutr Biochem. 22 (2011) 276-281. https://doi.org/10.1016/j.jnutbio.2010.02.005.

Food Science and Human Wellness
Pages 3256-3265
Cite this article:
Ganjayi MS, Sankaran KR, Meriga B, et al. Astragalin and rutin restore gut microbiota dysbiosis, alleviate obesity and insulin resistance in high-fat diet-fed C57BL/6J mice. Food Science and Human Wellness, 2024, 13(6): 3256-3265. https://doi.org/10.26599/FSHW.2023.9250012
Metrics & Citations  
Article History
Copyright
Rights and Permissions
Return